Loading...

Decarbonization And US Supply Chains Will Generate Future Momentum

Published
08 Nov 24
Updated
17 Apr 26
Views
79
17 Apr
₩351,000.00
AnalystConsensusTarget's Fair Value
₩421,500.00
16.7% undervalued intrinsic discount
Loading
1Y
92.4%
7D
-6.1%

Author's Valuation

₩421.5k16.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 17 Apr 26

Fair value Decreased 2.68%

A051910: Governance Reforms And Higher Future P E Will Support Upside

Analysts have nudged their fair value estimate for LG Chem down from ₩433,115 to ₩421,500, reflecting a slightly lower revenue growth outlook and profit margin assumptions, along with a modestly adjusted discount rate and future P/E.

What's in the News

  • Frontier Medicines granted LG Chem an exclusive worldwide license to develop and commercialize FMC-220 outside of Greater China. LG Chem will take responsibility for regulatory filings, global clinical development, and commercialization in its territories. Frontier will receive an upfront payment plus potential milestones and mid single digit to double digit royalties on net sales (Key Developments).
  • Palliser Capital said it was encouraged by the outcome of LG Chem's March 31, 2026 Annual General Meeting. It noted majority support from minority shareholders for its proposals and called for the Board, including the independent Chair, to address governance and capital allocation concerns to support long term shareholder value (Key Developments).
  • Proxy advisory firms Institutional Shareholder Services, Glass Lewis, Korea Corporate Governance Service, and Sustinvest recommended that LG Chem shareholders support key elements of Palliser Capital's governance proposals ahead of the March 31, 2026 General Meeting, aimed at strengthening the voice of minority shareholders on the board (Key Developments).
  • Palliser Capital highlighted what it described as a KRW 60 trillion value gap at LG Chem and continued to push for governance changes, following extensive engagement with the company ahead of the 2026 Ordinary General Meeting (Key Developments).
  • LG Chem announced an annual dividend of KRW 2,000.0000 per share, with an ex date of March 30, 2026, a record date of March 31, 2026, and payment scheduled for April 30, 2026 (Key Developments).

Valuation Changes

  • Fair Value: Trimmed from ₩433,115 to ₩421,500 per share, reflecting slightly softer assumptions across the model.
  • Discount Rate: Adjusted marginally lower from 9.76% to 9.60%, implying a slightly lower required rate of return.
  • Revenue Growth: Assumed revenue growth reduced from 12.56% to 10.95%, indicating more conservative expectations for future top line expansion.
  • Net Profit Margin: Target profit margin eased from 4.82% to 4.75%, suggesting a modestly tighter view on profitability.
  • Future P/E: Forward P/E multiple raised from 17.22x to 17.71x, pointing to a somewhat higher valuation multiple applied to future earnings.
3 viewsusers have viewed this narrative update

Key Takeaways

  • Strategic investments in U.S. battery materials and premium product portfolios position LG Chem to capture market share and margin growth amid global electrification and supply chain shifts.
  • Enhanced R&D, targeted M&As, and cost optimization in both chemicals and life sciences underpin earnings stability and support long-term growth in high-value, resilient sectors.
  • Diminished EV demand, regulatory hurdles, declining petrochemical volumes, and heavy capital spending threaten LG Chem's margins, cash flow, and financial flexibility.

Catalysts

About LG Chem
    Engages in the petrochemicals, energy, advanced materials, and life science businesses in Korea, China, Asia/Oceania, the United States, Europe, and internationally.
What are the underlying business or industry changes driving this perspective?
  • The ongoing global push towards decarbonization and electrification, including policies supporting EV penetration and green technologies, remains a long-term tailwind for LG Chem's battery materials and eco-friendly products. Despite temporary headwinds from subsidy phaseouts, preparations for production ramp-up in North America in 2026 and new supply contracts (e.g., with Toyota) signal a pathway to renewed volume growth and margin recovery in the medium term, positively affecting future revenue and earnings.
  • The shift by OEMs towards non-China supply chains and the tightening of regulations around sourcing for EV batteries create a significant opportunity for LG Chem's U.S.-based cathode plant and vertically integrated value chain. As customers seek local and non-China supply, LG Chem's early investments position it to capture both market share and price premiums, supporting higher revenue and improved net margins.
  • The focus on expanding the high-value portfolio (e.g., premium ABS, synthetic rubber, specialty chemicals) and active restructuring of commodity and intermediate operations aligns with industry trends favoring high-performance and sustainable materials, which is expected to lift blended margins and drive more resilient earnings as demand for basic petrochemical products moderates.
  • Accelerating R&D efforts and targeted M&As in Life Sciences, with a focus on areas like oncology, immunology, and advanced pharmaceutical candidates, tap into the growing global healthcare needs and aging populations, supporting long-term revenue growth, stable milestone income, and a higher contribution from high-margin specialty businesses.
  • The company's ongoing optimization of operations, cost reduction initiatives, active portfolio rebalancing, and prudent use of asset proceeds (e.g., from business divestitures) bolster financial flexibility and cash flow. This enables continued investment in growth engines and support for shareholder returns, positioning LG Chem for enhanced earnings stability and capital deployment in a transforming industry landscape.
LG Chem Earnings and Revenue Growth

LG Chem Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming LG Chem's revenue will grow by 10.9% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -5.7% today to 4.7% in 3 years time.
  • Analysts expect earnings to reach ₩2977.3 billion (and earnings per share of ₩40174.26) by about April 2029, up from -₩2638.8 billion today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting ₩5779.3 billion in earnings, and the most bearish expecting ₩1670.0 billion.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 17.9x on those 2029 earnings, up from -10.7x today. This future PE is greater than the current PE for the KR Chemicals industry at 15.7x.
  • Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.6%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Weakening demand for EVs in the U.S. driven by the sunset of IRA subsidies, lifting of fuel efficiency regulations, and new tariffs is expected to cause a contraction in LG Chem's cathode materials business through 2025, leading to reduced shipments and worsening profitability, directly impacting revenues and net margins.
  • Persistently cautious inventory management by major customers and project delays in the battery materials segment point to near-term volume declines and loss-making quarters, suggesting that earnings volatility may remain elevated until at least 2026.
  • Ongoing tariff disputes (U.S.-Korea reciprocal tariffs, IRA content restrictions) as well as increasing regulatory barriers (PFE regulations) raise structural costs and could erode LG Chem's cost competitiveness in key segments, creating sustained margin pressure.
  • Petrochemical demand outlook remains muted as global overcapacity, China's uncertain restructuring policy, and ongoing U.S. tariff barriers combine to hold down product volumes and limit recovery potential, thereby weighing on overall cash flow and profitability.
  • Large capital expenditure requirements for plant construction (e.g., U.S. cathode plant, bio oil ecosystem) and a continued shift toward high-value/high-growth segments may strain free cash flow, increasing reliance on asset sales or borrowings, which could weaken balance sheet stability and limit shareholder distributions.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of ₩421500.0 for LG Chem based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of ₩520000.0, and the most bearish reporting a price target of just ₩298000.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be ₩62731.4 billion, earnings will come to ₩2977.3 billion, and it would be trading on a PE ratio of 17.9x, assuming you use a discount rate of 9.6%.
  • Given the current share price of ₩360000.0, the analyst price target of ₩421500.0 is 14.6% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on LG Chem?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

₩344.88k
FV
1.8% overvalued intrinsic discount
81
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative